Cebix Obtains $8,799,305 New Financing Round

  • Feed Type
  • Date
    3/9/2012
  • Company Name
    Cebix
  • Mailing Address
    1298 Prospect Street La Jolla, CA 92037
  • Company Description
    Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.
  • Website
    http://www.cebix.com
  • Transaction Type
    Debt
  • Transaction Amount
    $8,799,305
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.